TATX-06

N/A

Report date: 2025/01/26 15:48:48

Base Information

Drug NameTATX-06
Drug Alias Namebispecific antibody (Talem Therapeutics)TATX-06
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19) +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalem Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesTalem Therapeutics LLC
Inactive CompaniesImmunoPrecise Antibodies Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A